Search Results 771-780 of 38069 for Two-phase
... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...
A recently published multicenter, randomized phase 2 study failed to demonstrate benefit of HIPEC with carboplatin for platinum-sensitive recurrent ovarian ...
This is a multicenter, open-label, two-population, single-arm study with a sequential dose-escalation and dose-expansion in adult subjects with progressive ...
Don't lie down for two hours after a meal. Take a ... The results of a phase 2 trial found that the drug could speed up gastric emptying and ease vomiting.
These steps may help find and manage glaucoma in its early stages. That may ... 2 to 4 years if you're 40 to 54 years old; every 1 to 3 years if you're 55 to 64 ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
... stage breast cancer. In the phase 3 monarchE trial, two years of abemaciclib (Verzenio) plus endocrine therapy reduced the risk of death by 15.8% compared ...
The study consists of two stages: in the Dose Escalation Stage, an appropriate recommended cabozantinib dose for the combination with standard dosing ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
The purpose of this study is to establish the recommended phase 2 dose (RP2D) of niraparib combination therapies of Part 1 and to evaluate the antitumor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.